Global Gastrointestinal Stromal Tumor (GIST) Market: Size, Trends, and Strategic Insights The gastrointestinal stromal tumor (GIST) industry is undergoing sizeable transformation driven by advances in targeted therapies and increasing patient awareness. The growing clinical focus on personalized medicine and innovative treatment options has propelled significant industry growth, making GIST a focal point for pharma and biotech market companies. Market analysis indicates robust expansion across multiple segments, fueled by evolving market dynamics and emerging treatment paradigms. Market Size and Overview The Global Gastrointestinal Stromal Tumor (GIST) market size is estimated to be valued at USD 1.32 billion in 2026 and is expected to reach USD 2.54 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.8% from 2026 to 2032. Global Gastrointestinal Stromal Tumor (GIST) Market:https://www.coherentmi.com/industry-reports/gastrointestinal-stromal-tumor-gist-market